Liminatus Pharma Stock (NASDAQ:LIMN)
Previous Close
$1.53
52W Range
$1.12 - $33.66
50D Avg
$2.76
200D Avg
$6.60
Market Cap
$38.16M
Avg Vol (3M)
$1.49M
Beta
0.38
Div Yield
-
LIMN Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.